Hopital Mignot

Le Chesnay 78157

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Myelodysplastic Syndromes

Studies at this site

• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML — Completed